Compile Data Set for Download or QSAR
Report error Found 82 Enz. Inhib. hit(s) with all data for entry = 50034594
TargetCannabinoid receptor 1(Rat)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataEC50:  85nMAssay Description:Agonist activity at CB1 receptor in rat brain tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364936(CHEMBL1950352)
Affinity DataEC50:  150nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataEC50:  49nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364921(CHEMBL1950329)
Affinity DataEC50:  6nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364935(CHEMBL1950350)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364934(CHEMBL1950349)
Affinity DataEC50:  473nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364933(CHEMBL1950348)
Affinity DataEC50:  50nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364953(CHEMBL1950338)
Affinity DataEC50:  5.42E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364954(CHEMBL1950339)
Affinity DataEC50:  1.36E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364922(CHEMBL1950330)
Affinity DataEC50:  768nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364925(CHEMBL1950340)
Affinity DataEC50:  45nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364926(CHEMBL1950341)
Affinity DataEC50:  103nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364930(CHEMBL1950345)
Affinity DataEC50:  117nMAssay Description:Partial agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Rat)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364922(CHEMBL1950330)
Affinity DataEC50:  1.44E+3nMAssay Description:Agonist activity at CB1 receptor in rat brain tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364927(CHEMBL1950342)
Affinity DataEC50:  4.25E+3nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364928(CHEMBL1950343)
Affinity DataEC50:  77nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364929(CHEMBL1950344)
Affinity DataEC50:  63nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364939(CHEMBL1950355)
Affinity DataEC50:  71nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364952(CHEMBL1950337)
Affinity DataEC50: >1.40E+4nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364951(CHEMBL1950336)
Affinity DataEC50:  60nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364924(CHEMBL1950335)
Affinity DataEC50:  60nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364950(CHEMBL1950334)
Affinity DataEC50:  5nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364932(CHEMBL1950347)
Affinity DataEC50:  22nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364931(CHEMBL1950346)
Affinity DataEC50:  129nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364941(CHEMBL1950357)
Affinity DataEC50:  53nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364937(CHEMBL1950353)
Affinity DataEC50:  59nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364949(CHEMBL1950332)
Affinity DataEC50:  115nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364938(CHEMBL1950354)
Affinity DataEC50:  26nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364948(CHEMBL1950331)
Affinity DataEC50:  103nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50218116(naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methan...)
Affinity DataEC50:  72nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364923(CHEMBL1950333)
Affinity DataEC50:  33nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM60994((10R,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tet...)
Affinity DataEC50:  17nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Mouse)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 1.90nMAssay Description:Agonist activity at CB1 receptor in field-stimulated mouse vas deferensMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364931(CHEMBL1950346)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of human Erg by voltage ion flux electrophysiological assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364946(CHEMBL1950489)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of human Erg by voltage ion flux electrophysiological assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of human Erg by voltage ion flux electrophysiological assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human DORMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human KORMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human MORMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364944(CHEMBL1950487)
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human Erg by voltage ion flux electrophysiological assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364947(CHEMBL1950490)
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of human Erg by voltage ion flux electrophysiological assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364945(CHEMBL1950488)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human Erg by voltage ion flux electrophysiological assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364921(CHEMBL1950329)
Affinity DataKi:  0.560nMAssay Description:Binding affinity to human CB2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364921(CHEMBL1950329)
Affinity DataKi:  3nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364923(CHEMBL1950333)
Affinity DataKi:  9nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 82 total ) | Next | Last >>
Jump to: